Bernadette Biondi

Summary

Country: Italy

Publications

  1. doi Cardiovascular involvement in patients with different causes of hyperthyroidism
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Nat Rev Endocrinol 6:431-43. 2010
  2. doi Mechanisms in endocrinology: Heart failure and thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Italy
    Eur J Endocrinol 167:609-18. 2012
  3. doi Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 161:323-9. 2009
  4. doi Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Thyroid 20:135-46. 2010
  5. ncbi The clinical significance of subclinical thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Endocr Rev 29:76-131. 2008
  6. ncbi Thyroid-hormone therapy and thyroid cancer: a reassessment
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Nat Clin Pract Endocrinol Metab 1:32-40. 2005
  7. doi Natural history, diagnosis and management of subclinical thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Best Pract Res Clin Endocrinol Metab 26:431-46. 2012
  8. ncbi Subclinical hyperthyroidism: clinical features and treatment options
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, 80131 Naples, Italy
    Eur J Endocrinol 152:1-9. 2005
  9. doi Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    J Clin Endocrinol Metab 97:2256-71. 2012
  10. ncbi Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, 80131 Naples, Italy
    J Clin Endocrinol Metab 88:211-4. 2003

Detail Information

Publications21

  1. doi Cardiovascular involvement in patients with different causes of hyperthyroidism
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Nat Rev Endocrinol 6:431-43. 2010
    ..Consequently, the etiology of hyperthyroidism must be established to enable correct treatment of the disease and the cardiovascular complications...
  2. doi Mechanisms in endocrinology: Heart failure and thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Italy
    Eur J Endocrinol 167:609-18. 2012
    ..The aim of this review article was to assess the results of the prospective studies that evaluated the risk of HF in patients with overt and subclinical thyroid disease and discuss the mechanism of this dysfunction...
  3. doi Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 161:323-9. 2009
    ..Although coronary flow reserve (CFR) is reduced in patients with subclinical hypothyroidism (SHypo), the endothelial response of coronary vasomotion has never been explored in this clinical setting...
  4. doi Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Thyroid 20:135-46. 2010
    ....
  5. ncbi The clinical significance of subclinical thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Endocr Rev 29:76-131. 2008
    ..Lastly, we address the issue of the need to treat slight thyroid hormone deficiency or excess in relation to the patient's age...
  6. ncbi Thyroid-hormone therapy and thyroid cancer: a reassessment
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Nat Clin Pract Endocrinol Metab 1:32-40. 2005
    ..5 mU/l). Only selected patients with high-risk papillary and follicular thyroid cancer require long-term TSH-suppressive doses of L-T(4). In these patients, careful monitoring is necessary to avoid undesirable effects on bone and heart...
  7. doi Natural history, diagnosis and management of subclinical thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Best Pract Res Clin Endocrinol Metab 26:431-46. 2012
    ..Mild SHypo should be treated in infertile and pregnant women...
  8. ncbi Subclinical hyperthyroidism: clinical features and treatment options
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, 80131 Naples, Italy
    Eur J Endocrinol 152:1-9. 2005
    ..Subclinical hyperthyroidism and its related clinical manifestations are reversible and may be prevented by timely treatment...
  9. doi Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    J Clin Endocrinol Metab 97:2256-71. 2012
    ..The aim of this review is to assess the physiological basis and the results of current studies on this topic...
  10. ncbi Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, 80131 Naples, Italy
    J Clin Endocrinol Metab 88:211-4. 2003
    ..Our data demonstrate that rhTSH does not alter cardiovascular function acutely. Consequently, it can safely be used in the routine staging of patients affected by differentiated thyroid cancer...
  11. doi Impact of resistance to thyroid hormone on the cardiovascular system in adults
    Melania Pulcrano
    Department of Clinical and Molecular Endocrinology and Oncology, University Federico II of Naples, Via S Pansini 5, Naples, Italy
    J Clin Endocrinol Metab 94:2812-6. 2009
    ..The clinical manifestations of resistance to thyroid hormone (RTH) are highly variable, and the impact of RTH on the cardiovascular system has been poorly investigated...
  12. doi Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease
    Ferruccio Santini
    Endocrinology UnitObesity Center, University Hospital of Pisa, Pisa, ItalyDepartment of Translational MedicineUniversity of Piemonte Orientale, Novara, ItalyDivision of General MedicineI R C C S Istituto Auxologico Italiano, Verbania, ItalyUnit of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri I R C C S, University of Pavia, Pavia, ItalyDepartment of Clinical Medicine and SurgeryUniversity of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 171:R137-52. 2014
    ..While thyroid hormones are not indicated as anti-obesity drugs, preclinical studies suggest that thyromimetic drugs, by targeting selected receptors, might be useful in the treatment of obesity and dyslipidemia. ..
  13. doi How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism?
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 167:295-9. 2012
    ..Randomized controlled clinical trials are needed to assess the benefits of treatment to improve the cardiovascular mortality and morbidity of mild and overt hyperthyroidism...
  14. ncbi Hypothyroidism as a risk factor for cardiovascular disease
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, Via S Pansini 5, 80131, Naples, Italy
    Endocrine 24:1-13. 2004
    ..This constellation of reversible cardiovascular abnormalities in patient with TSH levels <10 mU/L indicate that the benefits of treatment of mild thyroid failure with appropriate doses of L-thyroxine outweigh the risk...
  15. pmc Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
    Bernadette Biondi
    Department of Clinical and Molecular, Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Biologics 3:9-13. 2009
    ..More studies are required to establish the amount of radioiodine to be administered especially in high-risk patients...
  16. doi Invited commentary: Cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 162:587-9. 2010
    ....
  17. ncbi Effects of subclinical thyroid dysfunction on the heart
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, 80131 Naples, Italy
    Ann Intern Med 137:904-14. 2002
    ..Mounting evidence indicates that subclinical thyroid dysfunction has important clinical effects and prognostic implications, supporting the view that it is not a compensated biochemical change sensu strictu...
  18. doi Treatment with thyroid hormone
    Bernadette Biondi
    Department of Clinical Medicine and Surgery B B, University of Naples Federico II, 80131 Naples, Italy and Washington Hospital Center L W, Washington, D C 20010
    Endocr Rev 35:433-512. 2014
    ..Lastly, we address the potential use of thyroid hormones or their analogs in obese patients and in severe cardiac diseases, dyslipidemia, and nonthyroidal illnesses. ..
  19. ncbi Cardiovascular effects of mild hypothyroidism
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Thyroid 17:625-30. 2007
    ....
  20. ncbi Should we treat all subjects with subclinical thyroid disease the same way?
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Eur J Endocrinol 159:343-5. 2008
  21. ncbi Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia
    Annamaria Colao
    Department of Molecular and Clinical Endocrinology, Federico II University of Naples, Via S Pansini 5, Italy
    Eur J Endocrinol 148:325-31. 2003
    ..Whether this reflects only a delay in diagnosis in men or a true gender difference in tumor pathogenesis is still unclear...